biotech

Evolus & Urovant: Similar Strategies, Opposite Reactions to Positive Catalysts
Gallery
Evolus & Urovant: Similar Strategies, Opposite Reactions to Positive Catalysts

Bill Langbein, Case Study, Education, Healthcare, Insights, Pharmaceutical & Biotechnology

Evolus & Urovant: Similar Strategies, Opposite Reactions to Positive Catalysts

By Bill Langbein|2019-03-25T11:45:49-04:00March 25th, 2019|Categories: Bill Langbein, Case Study, Education, Healthcare, Insights, Pharmaceutical & Biotechnology|Tags: biotech, Botox, Recro, REPH, SanaCurrents|

One of the strongest performing biopharmaceutical stocks this year is [...]

0

SanaCurrents Introduction – Turn to the Biotech Experts to Maximize Your Returns
Gallery
SanaCurrents Introduction – Turn to the Biotech Experts to Maximize Your Returns

Bill Langbein, Health Care Equipment & Services, Healthcare, Insights, Pharmaceutical & Biotechnology

SanaCurrents Introduction – Turn to the Biotech Experts to Maximize Your Returns

By GeoTeam|2019-05-03T11:54:55-04:00November 4th, 2018|Categories: Bill Langbein, Health Care Equipment & Services, Healthcare, Insights, Pharmaceutical & Biotechnology|Tags: Bill Langbein, biotech, FDA, healthcare, medical devices, Pharmaceuticals & Biotechnology, SanaCurrents|

Introducing SanaCurrents Introducing SanaCurrents, a research service for the serious [...]

0

Welcome to SanaCurrents
Gallery
Welcome to SanaCurrents

Bill Langbein, Health Care Equipment & Services, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents

Welcome to SanaCurrents

By Bill Langbein|2018-12-04T12:07:49-04:00October 28th, 2018|Categories: Bill Langbein, Health Care Equipment & Services, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents|Tags: Bill Langbein, biotech, FDA, healthcare, medical devices, Pharmaceuticals & Biotechnology, SanaCurrents|

Life science investing always has been a roller coaster ride, [...]

0